Paul K Witting (PhD)
Senior Scientist

ANZAC Research Institute,
Concord Repatriation General Hospital

Discipline of Pathology
The University of Sydney

Email Paul Witting, here

Dr Paul Witting is a Senior Lecturer in the Discipline of Pathology at The University of Sydney and a career biomedical researcher. He has held ARC (2003-2007) and National Heart Foundation Fellowships (1999-2001) that financed post-doctoral terms at the ANZAC Research Institute and University of British Columbia (Canada), respectively. He has a proven track record in the field of bio-medical chemistry publishing 61 peer-reviewed papers (mean impact factor (IF) ~4.6 with >90% appearing in international journals); 4-book chapters; 9-invited review articles and one International Patent. Witting is first or senior author in ~65% of his papers and his work has been acknowledged with 1310 citations (mean citation/publication ~23 yielding an H-index ~23). He has been awarded ~A$3.7 Million in competitive funding from agencies including the ARC, NHF, Wellcome Trust, NHMRC Equipment Grants, The Ramaciotti, Bushell and CASS Foundations, Eli Lilly Diabetes Foundation, Diabetes Australia Research Trust and the University of Sydney Strategic Development Grants Scheme.

In July of 2008 Witting moved from the ANZAC Research Institute to take up a full time Senior Lectureship and establish the Redox Biology Group in the Discipline of Pathology, The University of Sydney. As part of this relocation Witting has been awarded over $175 K in start-up funding that includes a newly renovated laboratory with up-to-date equipment. The new facility combined with significant funding from the Heart Foundation and the ARC over the next 2-3 years provides an excellent environment for young researchers to be trained in biomedical techniques and explore the relationships between oxidative stress and disease.

Dr Witting’s research interest is in exploring the relationship between oxidative stress and the evolution of tissue damage in the acute setting of stroke and myocardial infarct. He is also collaborating with clinicians in the Concord Hospital Burn Unit as he examines the relationship between severe burn and acute renal failure.